Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Naa40em1/Cya
Common Name:
Naa40-KO
Product ID:
S-KO-20385
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Naa40-KO
Strain ID
KOCMP-70999-Naa40-B6J-VB
Gene Name
Naa40
Product ID
S-KO-20385
Gene Alias
4931433E08Rik; Nat11; NatD
Background
C57BL/6JCya
NCBI ID
70999
Modification
Conventional knockout
Chromosome
19
Phenotype
MGI:1918249
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Naa40em1/Cya mice (Catalog S-KO-20385) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000025675
NCBI RefSeq
NM_027643
Target Region
Exon 2~3
Size of Effective Region
~2.3 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Naa40, also known as N-alpha-acetyltransferase 40, is a highly specific epigenetic enzyme. It catalyzes the transfer of an acetyl moiety to the alpha-amino group of serine 1 on histones H4 and H2A. This histone N-terminal acetylation is involved in regulating gene expression, chromatin function, and is associated with various biological processes such as metabolism and cancer development [1,2,3,4,5,6,7,8].

Depletion of Naa40 in CRC cell lines inhibits cell proliferation, survival, and increases their sensitivity to 5-Fluorouracil treatment. In vivo, the absence of Naa40 significantly delays the growth of human CRC xenograft tumors. Naa40 knockdown reduces the levels of symmetric dimethylation of histone H4 through transcriptional downregulation of PRMT5, leading to altered expression of key oncogenes and tumor suppressor genes [1]. In murine hepatocytes, Naa40 depletion increases intracellular acetyl-CoA levels, enhancing lipid synthesis, which is also replicated in Drosophila melanogaster larval fat body [2]. In CRC cells, Naa40 controls key one-carbon metabolic genes and metabolites, promoting resistance to antimetabolite chemotherapy [3]. In hepatocellular carcinoma, high Naa40 expression correlates with poor prognosis, and is associated with T stage, pathologic stage, etc., while having an inverse correlation with immune cell infiltration [5]. In osteosarcoma cells, Naa40 depletion reduces cell viability, migration, and invasion, and in vivo, it inhibits the proliferative and metastatic potential of these cells by epigenetically regulating AGR2 expression [6]. In colorectal cancer cells, Naa40 depletion induces p53-independent apoptosis via the mitochondrial pathway [7].

In conclusion, Naa40 plays crucial roles in multiple biological processes and diseases. Its functions in cancer, metabolism, and immune regulation have been revealed through various loss-of-function experiments including in vitro cell lines and in vivo xenograft models. These findings highlight Naa40 as a potential therapeutic target in diseases such as colorectal cancer, liver cancer, and osteosarcoma.

References:
1. Demetriadou, Christina, Pavlou, Demetria, Mpekris, Fotios, Papageorgis, Panagiotis, Kirmizis, Antonis. 2019. NAA40 contributes to colorectal cancer growth by controlling PRMT5 expression. In Cell death & disease, 10, 236. doi:10.1038/s41419-019-1487-3. https://pubmed.ncbi.nlm.nih.gov/30858358/
2. Charidemou, Evelina, Tsiarli, Maria A, Theophanous, Andria, Griffin, Julian L, Kirmizis, Antonis. 2022. Histone acetyltransferase NAA40 modulates acetyl-CoA levels and lipid synthesis. In BMC biology, 20, 22. doi:10.1186/s12915-021-01225-8. https://pubmed.ncbi.nlm.nih.gov/35057804/
3. Demetriadou, Christina, Raoukka, Anastasia, Charidemou, Evelina, Tessarz, Peter, Kirmizis, Antonis. 2021. Histone N-terminal acetyltransferase NAA40 links one-carbon metabolism to chemoresistance. In Oncogene, 41, 571-585. doi:10.1038/s41388-021-02113-9. https://pubmed.ncbi.nlm.nih.gov/34785778/
4. Koufaris, Costas, Kirmizis, Antonis. 2021. Identification of NAA40 as a Potential Prognostic Marker for Aggressive Liver Cancer Subtypes. In Frontiers in oncology, 11, 691950. doi:10.3389/fonc.2021.691950. https://pubmed.ncbi.nlm.nih.gov/34150665/
5. Zhou, Tong, Cao, Jun, Tang, Qingqin, Liang, Yuting, Feng, Bin. 2024. Exploring the role of NAA40 in immune infiltrates and prognostic prediction in hepatocellular carcinoma. In American journal of clinical and experimental immunology, 13, 26-34. doi:. https://pubmed.ncbi.nlm.nih.gov/38496356/
6. Wu, Hanhua, Xu, Hua, Man, Yunan, Huang, Linhai, He, Maolin. 2025. N-terminal histone acetyltransferase NAA40 modulates osteosarcoma progression by controlling AGR2 expression. In Biochemical and biophysical research communications, 754, 151491. doi:10.1016/j.bbrc.2025.151491. https://pubmed.ncbi.nlm.nih.gov/40020320/
7. Pavlou, Demetria, Kirmizis, Antonis. . Depletion of histone N-terminal-acetyltransferase Naa40 induces p53-independent apoptosis in colorectal cancer cells via the mitochondrial pathway. In Apoptosis : an international journal on programmed cell death, 21, 298-311. doi:10.1007/s10495-015-1207-0. https://pubmed.ncbi.nlm.nih.gov/26666750/
8. Constantinou, Mamantia, Klavaris, Ariel, Koufaris, Costas, Kirmizis, Antonis. 2023. Cellular effects of NAT-mediated histone N-terminal acetylation. In Journal of cell science, 136, . doi:10.1242/jcs.260801. https://pubmed.ncbi.nlm.nih.gov/37013828/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest